Literature DB >> 16120420

Mitochondrial dysfunction in chronic ischemia and peripheral vascular disease.

Graham J Kemp1.   

Abstract

In peripheral vascular disease, impaired muscle energy metabolism is assumed to be due mainly to defective vascular O2 supply, the resulting cellular hypoxia inhibiting oxidative ATP synthesis. Older work suggested a compensatory increase in muscle aerobic enzymes, but more recent studies suggest a relative decrease in some mitochondrial components and an accumulation of damage in mitochondrial DNA, perhaps due to reactive oxygen species. However, to establish whether in vivo muscle mitochondria suffer from anything other than a low concentration of O2 will require more knowledge of the mitochondrial behaviour at low PO2, and the actual cell PO2 during exercise.

Entities:  

Year:  2004        PMID: 16120420     DOI: 10.1016/j.mito.2004.07.017

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  12 in total

1.  Antioxidants and aging: NMR-based evidence of improved skeletal muscle perfusion and energetics.

Authors:  D Walter Wray; Steven K Nishiyama; Aurélien Monnet; Claire Wary; Sandrine S Duteil; Pierre G Carlier; Russell S Richardson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-09-18       Impact factor: 4.733

2.  Muscle strength and control characteristics are altered by peripheral artery disease.

Authors:  Molly N Schieber; Ryan M Hasenkamp; Iraklis I Pipinos; Jason M Johanning; Nicholas Stergiou; Holly K DeSpiegelaere; Jung H Chien; Sara A Myers
Journal:  J Vasc Surg       Date:  2017-07       Impact factor: 4.268

3.  Chronically ischemic mouse skeletal muscle exhibits myopathy in association with mitochondrial dysfunction and oxidative damage.

Authors:  Iraklis I Pipinos; Stanley A Swanson; Zhen Zhu; Aikaterini A Nella; Dustin J Weiss; Tanuja L Gutti; Rodney D McComb; B Timothy Baxter; Thomas G Lynch; George P Casale
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-05-14       Impact factor: 3.619

4.  Oxygen availability and skeletal muscle oxidative capacity in patients with peripheral artery disease: implications from in vivo and in vitro assessments.

Authors:  Corey R Hart; Gwenael Layec; Joel D Trinity; Yann Le Fur; Jayson R Gifford; Heather L Clifton; Russell S Richardson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-06-22       Impact factor: 4.733

5.  V.O2 Kinetics and clinical factors among patients with peripheral artery disease.

Authors:  Raphael Mendes Ritti-Dias; Ji Li; Kimberly M Hollabaugh; Julie A Stoner; Polly S Montgomery; Andrew W Gardner
Journal:  J Cardiopulm Rehabil Prev       Date:  2013 Nov-Dec       Impact factor: 2.081

6.  Supplemental oxygen and muscle metabolism in mitochondrial myopathy patients.

Authors:  Michael I Trenell; Carolyn M Sue; Campbell H Thompson; Graham J Kemp
Journal:  Eur J Appl Physiol       Date:  2007-01-12       Impact factor: 3.078

7.  The reproducibility of 31-phosphorus MRS measures of muscle energetics at 3 Tesla in trained men.

Authors:  Lindsay M Edwards; Damian J Tyler; Graham J Kemp; Renee M Dwyer; Andrew Johnson; Cameron J Holloway; Alan M Nevill; Kieran Clarke
Journal:  PLoS One       Date:  2012-06-11       Impact factor: 3.240

Review 8.  Mitochondrial Bioenergetics in the Metabolic Myopathy Accompanying Peripheral Artery Disease.

Authors:  Victoria G Rontoyanni; Omar Nunez Lopez; Grant T Fankhauser; Zulfiqar F Cheema; Blake B Rasmussen; Craig Porter
Journal:  Front Physiol       Date:  2017-03-13       Impact factor: 4.566

9.  Plasma Energy-Balance Metabolites Discriminate Asymptomatic Patients with Peripheral Artery Disease.

Authors:  Anna Hernández-Aguilera; Salvador Fernández-Arroyo; Noemí Cabre; Fedra Luciano-Mateo; Gerard Baiges-Gaya; Montserrat Fibla; Vicente Martín-Paredero; Javier A Menendez; Jordi Camps; Jorge Joven
Journal:  Mediators Inflamm       Date:  2018-09-20       Impact factor: 4.711

Review 10.  Oxidative stress and antioxidant treatment in patients with peripheral artery disease.

Authors:  Panagiotis Koutakis; Ahmed Ismaeel; Patrick Farmer; Seth Purcell; Robert S Smith; Jack L Eidson; William T Bohannon
Journal:  Physiol Rep       Date:  2018-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.